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Abstract A continuing challenge for preclinical 
research on anxiolytic drugs is to capture the affective 
dimension that characterizes anxiety and aggression, 
either in their adaptive forms or when they become of 
clinical concern. Experimental protocols for the pre- 
clinical study of anxiolytic drugs typically involve the 
suppression of  conditioned or unconditioned social and 
exploratory behavior (e.g., punished drinking or social 
interactions) and demonstrate the reversal of  this 
behavioral suppression by drugs acting on the benzo- 
diazepine-GABAA complex. Less frequently, aversive 
events engender increases in conditioned or uncondi- 
tioned behavior that are reversed by anxiolytic drugs 
(e.g., fear-potentiated startle). More recently, putative 
anxiolytics which target 5-HT receptor subtypes pro- 
duced effects in these traditional protocols that often 
are not systematic and robust. We propose ethological 
studies of vocal expressions in rodents and primates 
during social confrontations, separation from social 
companions, or exposure to aversive environmental 
events as promising sources of information on the 
affective features of behavior. This approach focusses 
on vocal and other display behavior with clear func- 
tional validity and homology. Drugs with anxiolytic 
effects that act on the benzodiazepine-GABAa recep- 
tor complex and o n  5-HT~A receptors systematically 
and potently alter specific vocalizations in rodents and 
primates in a pharmacologically reversible manner; the 
specificity of these effects on vocalizations is evident 
due to the effectiveness of low doses that do not corn- 
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promise other physiological and behavioral processes. 
Antagonists at the benzodiazepine receptor reverse the 
effects of  full agonists on vocalizations, particularly 
when these occur in threatening, startling and dis- 
tressing contexts. With the development of antagonists 
at 5-HT receptor subtypes, it can be anticipated that 
similar receptor-specificity can be established for the 
effects of  5-HT anxiolytics. 
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Introduction 
The neurobiological and psychopharmacological study 
of aggression and anxiety is faced with the initial chal- 
lenge of how to relate clinical and social concerns with 
pathological excesses to our understanding of these 
behaviors' ontogenetic and phylogenetic adaptive ori- 
gin. Clinicians and public health officials focus on an 
excess or, alternatively, a lack of anxious and aggres- 
sive behavior, while ethological analyses delineate the 
adaptive nature of these behavior patterns. The most 
global definitions of aggression and anxiety attempt to 
encompass adaptive as well as pathological forms. 
Alternatively, psychiatric and ethological definitions 
are offered that emphasize either the pathological 
extremes of aggression and anxiety or, alternatively, 
refer to their evolutionary roots and importance in the 
survival of  the individual and the species. One impor- 
tant dimension of aggressive and anxious behavior pat- 
terns that has eluded adequate quantitative assessment 
in clinical, as well as preclinical research, is the affective 
or emotional nature of these activities. Here we pro- 
pose that certain types of vocalizations may represent 
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aftbctive expressions that are accessible to quantitative 
behavioral and neuropharmacological preclinical inves- 
tigations. 
Clinical and preclinical traditions 
The nosological situation is considerably more satis- 
factory for "anxiety" than for "aggression" in clinical 
populations (Eichelman and Hartwig 1993). The 
Diagnostic and Statistical Manual of Mental Disorder 
IV (DSM IV) of the American Psychiatric Association 
(1994) clearly distinguishes several types of anxiety dis- 
orders, such as panic disordm, phobic disorder (e.g., 
agoraphobia, social phobia, and simple phobia), obses- 
sive-compulsive disorder, post-traumatic stress disor- 
der, generalized anxiety disorder (GAD), and organic 
anxiety syndrome. By contrast, the preclinical proto- 
cols have not achieved this degree of differentiation. In 
addition, anxiety can appear concurrently with other 
pathological states such as alcoholism, depression dis- 
orders, schizophrenia and organic brain disorders. Here 
we focus on benzodiazepine and 5-HT~A anxiolytics 
that are most effective in GAD (e.g., Lader and 
Petursson 1981; Greenblatt et al, t983; De Vry 1995). 
By contrast, aggression remains unrecognized as a 
diagnostic category in the DSM IV (American 
Psychiatric Association 1994), but aggressive behavior 
appears as a symptom in several disorders that include: 
mental retardation, attention deficit disorder, organic 
mental syndromes, schizophrenia, delusional disorder, 
brief reactive psychosis, mood disorders, anxiety 
disorder, dissociative disorders, impulse control disor- 
der, adjustment disorder and personality disorders 
(Eichelman 1987). Mysteriously, while ultimately every 
behavior is a function of brain activity, the recent pub- 
lic debate in the US reveals considerable reluctance in 
the social science community" to relate aggressive behav- 
ior to any neural function. On the other hand, pre- 
clinical research of aggressive behavior has been guided 
mainly by the objectives and methods of biomedical, 
social and ethological scientific traditions. 
From a biomedical perspective, aggression under 
inappropriate conditions is considered a disease caused 
by disordered neural activity that needs to be treated 
(Mark and Ervin 1970). Aggressive outbursts are part 
of the symptomatology of a range of psychiatric and 
neurological diseases (vide supra). In spite of many clin- 
ical case reports, it still remains poorly understood how, 
for example, seizure disorders are related to aggressive 
outbursts, and whether or not the neurobiological 
mechanisms for ictal and interictal events are related 
to those for explosive aggressive behavior (Eichelman 
1983). In fact, the limbic dyscontrol syndrome has been 
suggested to encompass both aggressive and seizure 
events (e.g., Monroe 1978). There is some success with 
the anticonvulsants phenobarbital or carbamazepine 
in the reduction of aggressive behavior (Tardiff 1983; 
Munizz et al. 1993). The historic Phineas Gage episode 
points to traumatic and toxic insults to the brain as 
sources for aggressive episodes (Siegal and Mirsky 
1994). 
The approach in the social sciences highlights 
environmental determinants of aggressive behavior 
and refers to aggression as antisocial behavior (e.g., 
Berkowitz 1993). Here, the causative factors are 
assigned to the distal living conditions, such as isolated, 
impoverished or crowded housing, or to proximal 
triggers, such as noxious and aversive stimuli. For more 
than 50 years, the omission of scheduled reinforcement 
or "frustrative non-reward" has been a prime example 
for aggression as antisocial activity (Dollard et al. 
1939). 
On the other hand, the ethological objectives in the 
study of aggressive behavior seek to understand the 
evolutionary origin and functional significance of these 
behavior patterns (Lorenz 1966; Marler 1976). The 
adaptive significance of aggressive behavior in repro- 
ductive contexts is apparent in dominance, territorial 
and maternal aggression when potential rivals or 
intruders are repulsed and the brood is defended 
(Huntingford and Turner 1987; Archer 1988). 
Preclinical research strategies for psychopharmaco- 
logical and neurobiological investigations of aggressive 
and anxious behavior patterns are primarily guided by 
pharmacological validation, with homologies across 
species remaining elusive. While aggressive and anx- 
ious behaviors are characterized by affective or emo- 
tional features, this dimension is rarely part of 
preclinical psychopharmacological research. In fact, 
most research during the past three decades suggests 
that anxiolytics with sites of action at the GABAa-ben- 
zodiazepine receptor complex and, more recently, the 
5-HTIA receptor profoundly and systematically modu- 
late animal behaviors that represent adaptations to 
aversive environmental events. 
Major preclinical research methods for predicting 
anxiolytic effects 
The many preclinical tests or "models" for the study 
of anxiolytic drugs can be grouped according to the 
type of experimental manipulations, the nature and 
direction of the behavioral change, and the resulting 
effects as predicting anxiolytic effects. Based on the 
effects of prototypic benzodiazepine drugs, the pre- 
clinical tests predict anxiolytic activity either by (i) 
restoring behavior that is suppressed by aversive con- 
tingencies, (2) attenuating behavior that is increased by 
aversive manipulations, or (3) reversing a pharmaco- 
logically induced "anxiogenic" state (e.g., File 1985; 
Handley 1991). Table 1 compares the effects of chlor- 
diazepoxide and diazepam as prototypic benzodi- 
azepines with the preclinical work on the potentially 
anxiolytic effects of buspirone as the first clinically 
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Table 1 Prectinical methods predicting anxiolytic effects - acute prototypic effects 
Method Benzodiazepine anxiolytics 5-HT agonists 
Drug Dose Effect Reference Drug Dose Effect 
(mg/kg) (mg/kg) 
Reference 
Restoration of  reversal of  behaviors suppressed by aversive contingency 
C Punished CDP 3-10 1" Barrett (1976) BUS 0.1-40 0/q" 
Operant (P) (R,P) 
Response 3-30 $ Barrett et al. (t986) BUS 0.001-0.3 I" 
(PG) (PG) 
U Plus-maze DZP 1-25 $ Klint (1991) BUS l $ 
Open-arm CDP 1-7.5 $ BUS 0.8 $ 
entry BUS 0.14.4 0 
Suppression of behaviors increased by aversive stimulus 
C Fear- DZP 0.3-2.5 -], Davis (1979) BUS 0.(>10 $ 
potentiated 
startle 
U Defensive DZP 0.5-2 $ Treit et al. (1981) BUS 0.05-1 $ 
burying 
Drug-induced anxiogenic states 
C PTZ- DZP 5-10 $ Lal and Shearman BUS 0.56 1" 
discrimination (1982) (IM)(P) 
BUS 0.56 1 0 
1-2 $ U Anxiety-like DZP Ninan et al. (1982) 
responses 
Barrett and Witkin (1991) 
Barrett et al. (1986) 
Klint (1991) 
File and Andrews (1991) 
File and Andrews (1991) 
Davis (1986) 
Treit and Fundytus (1988) 
Ator et al. (1989) 
Ator (1991) 
CDP chlordiazepoxide, DZP diazepam, BUS Buspirone. All doses refer to intraperitoneal administration, unless stated: (IM) intramus- 
cular route; (IV) intravenous route. C conditioned behavior, U unconditioned behavior, R rats, M mice, P primates, PG pigeons 
introduced serotonergic agent. Major reviews have 
summarized the effects of drugs that act at least par- 
tially as 5-HTIA receptor agonists in procedures that 
were developed for the benzodiazepine anxiolytics, i.e. 
that either (1) suppress behavior as a result of aversive 
contingencies or (2) engender behavior due to aversive 
stimulation (Chopin and Briley 1987; Barrett and 
Witkin 1991; Barrett and Vanover 1993; Handley and 
McBlane 1993; Handley et al. 1993). 
Restoration or reversal of behavior that is suppressed 
by aversive consequences 
The classic preclinical findings were obtained with pro- 
cedures that highlighted how benzodiazepines reversed 
the behaviorally suppressive effects of punishment such 
as those introduced by Geller and Seifter (1960), and 
by Vogel et al. (1971). For example, Sepinwall and Cook 
demonstrated systematic, dose-dependent benzodi- 
azepine effects on punishment-suppressed responding 
in squirrel monkeys that clearly differ from those on 
concurrently assessed non-punished responding 
(Sepinwall and Cook 1984). Of course, these proce- 
dures require considerable conditioning of the animal's 
behavior in order to obtain stable baselines of punished 
and unpunished responding. Yet, with a few well- 
trained animals systematic, dose-dependent, repeatable 
punishment-attenuating effects are seen with all ben- 
zodiazepine anxiolytics. The punishment-attenuating 
effects of full or partial benzodiazepine agonists are 
attenuated by antagonists such as flumazenil (Liljequist 
and Enget 1984). 
So far, the most persuasive preclinical evidence on 
systematic, reliable, dose-dependent attenuation of 
punishment-suppressed behavior by drugs with affinity 
for 5-HT1A receptors emerged from studies with 
pigeons, whereas similar studies in rats and primates 
remain only partially successful (Barett 1992; Sanger 
1992). Buspirone, an anxiolytic with some affinity for 
5-HTIA receptors, increases specifically punishment- 
suppressed responding without significantly affecting 
non-punished food-reinforced key-pecking in pigeons 
(Barrett and Witkin 1991). An agent with a more selec- 
tive affinity for the 5-HT~A receptor subtype, flesinoxan, 
proved to be also highly effective in increasing food- 
reinforced responding that was suppressed by punish- 
ment (Barrett et al. 1989). Notably, when given 
chronically, buspirone effectively attenuates punish- 
ment-suppressed behavior even in rats (Schefke et al. 
1989). A critical next step will be the reversal of these 
agonist effects by newly developed so-called silent 
antagonists in order to implicate the 5-HT1A receptor 
more adequately in these behavioral effects. 
In a research method that does not require condi- 
tioning, the focus is on exploratory behavior. In 
Montgomery's plus maze, rats readily enter into walled 
arms, but rarely into open arms of the apparatus 
(Montgomery 1955). This procedure does not require 
any training, but necessitates relatively inexperienced 
subjects for each test. Usually, behavioral specificity is 
assessed separately by measuring benzodiazepines' 
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effects on motor  activity. Peltow et al. (1985) demon- 
strated how benzodiazepines increase the time that rats 
spend in the open arms of a plus-maze which is inter- 
preted to reflect anxiolytic effects of these drugs. 
Flumazenil antagonizes the benzodiazepine effect on 
open arm entries (Wada and Fukuda  1991; Rex et al. 
1993). 
Similarly, buspirone and gepirone increase the time 
spent in the usually avoided open arm of a plus-maze, 
(S6derpatm et al. 1989). Similar effects have been 
reported for ondansetron, a drug acting at 5-HT3 recep- 
tors (Costall et al. 1988, 1989) but this effect appears 
less robust (File and Johnston 1989). 
Attenuation of behavior that is increased by aversive 
manipulations 
When exposed to certain aversive conditions animals 
display characteristic responses, some of them require 
conditioning such as the "fear"-potentiated startle, oth- 
ers simply measure how much effort is exerted to 
remove the aversive, noxious stimulus such as in a rat's 
"defensive burying." 
In the "fear"-potentiated startle procedure, increases 
in the startle reflex are measured when the presenta- 
tion of a light that has previously been paired repeat- 
edly with electric shock, immediately precedes a loud 
acoustic stimulus. Benzodiazepines are among the 
drugs that attenuate this increase in a dose-dependent 
fashion without altering the non-potentiated startle 
reflex (Davis 1979). The antagonist flumazenil blocks 
the diazepam effect on potentiated startle suggesting 
the benzodiazepine receptor as the relevant site of 
action for this effect (Berg and Davis 1984). 
Partial and full 5-HT1A receptor agonists have also 
effectively attenuated the "fear"-potentiated startle. For 
example, Buspirone and gepirone decreased in a dose- 
dependent, systematic manner the potentiated startle 
reflex (Kehne et al. 1988). So far, however, attempts to 
block buspirone effects with a range of serotonergic 
antagonists have been unsuccessful. Moreover, the pro- 
totypic 5-HTIA agonist 8-OH-DPAT, over a range of 
several doses, did not alter fear-potentiated startle, sug- 
gesting non-serotonergic mediation (Davis et al. 1988). 
Benzodiazepines suppress burying behavior of an 
electrified probe in rats that have been shocked previ- 
ously by the probe (Treit et al. 1981). This effect appears 
to be mediated via the benzodiazepine receptor, since 
ftumazenil blocked the suppressive effects of chlor- 
diazepoxide (Treit 1987). Similar to the benzodi- 
azepines, buspirone decreased defensive burying of the 
shock probe (Treit and Fundytus 1988), although these 
effects depend on specific testing parameters (Craft 
et al. 1988). 
Anxiolytics with different mechanisms of action 
appear to selectively attenuate conditioned and uncon- 
ditioned behavior that is engendered or amplified by 
exposure to aversive environmental events; these effects 
occur at non-sedative doses and without apparent 
development of tolerance (Sepinwall and Cook 1984; 
although see, for example, Vellucci and File 1979). 
Attenuation of drug-induced "anxiogenic" state 
A so-called anxiogenic state can be induced by phar- 
macological agents of several classes. Some procedures 
require elaborate conditioning such as the drug dis- 
crimination procedure, others simply engender a behav- 
ioral, physiological and neurochemical profile of 
"anxiety" responses as a result of drug administration. 
Lal and associates trained rats to discriminate 
pentylenetetrazol from saline in a two-lever choice task 
(Lal et al. 11988). The injection of either PTZ or saline 
served as the discriminative stimulus or "cue" defining 
which response on one of two levers was reinforced, 
i.e. "drug-appropriate". After the rats responded more 
than 90% of the time on the drug-appropriate lever, 
they were pretreated with benzodiazepine anxiolytics 
and demonstrated a systematic, dose-dependent atten- 
uation of the PTZ discriminative stimulus. Moreover, 
animals that are withdrawn from morphine, cocaine, 
alcohol or benzodiazepines generalize to the previously 
established PTZ discriminative stimulus, presumably on 
the basis of their withdrawal distress (Emmett-Oglesby 
et al. 1983, 1984; Lal et al. 1988; Wood et al. 1989). 
Recently, this pharmacological method to induce an 
anxiety-like state has attained considerable face-valid- 
ity. For example, rats that are exposed to a predator or 
to an attacking or threatening conspecific generalize 
this state to the previously conditioned PTZ 
discriminative stimulus (Vellucci et al. 1988; Gauvin 
and Holloway 1991; Vivian et al. 1994b). Most 
saline-injected rats, when exposed to an attacking or 
threatening opponent,  respond on the pentylenetetra- 
zol-appropriate operandum. Midazolam pretreatment 
prevents the substitution of the social stress for the PTZ 
stimulus (Vellucci et al. 1988; Vivian et al. 1994b). 
In chaired macaque monkeys, the IV injection of ~- 
CCE induced behavioral changes that included agitated 
responses and distress vocalizations (Ninan et al. 1982). 
These responses correlated with endocrine measures of 
stress and were attenuated by benzodiazepines and 
other anxiolytics (Crawley et al. 1985). While some 
behavioral features of these fl-CCE-treated monkeys 
are reminiscent of macaques that are threatened 
(Redmond and Huang 1979), the prerequisite of 
adaptation to chair-restraint for a stress-free baseline 
renders this experimental protocol in terms of face- 
validity. 
To summarize, benzodiazepines consistently and 
effectively attenuate the suppressive effects of punish- 
ment on conditioned and unconditioned behavior in 
various animal species including humans. Similarly, 
these drugs reduce so-called fear- or stress-induced 
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conditioned and unconditioned responses. Drug- 
induced "anxiogenic" states such as the pentylenete- 
trazol "cue" or the fl-CCE behavioral and physiological 
responses are attenuated by benzodiazepines. These 
anxiolytics achieve their behavioral effects via benzo- 
diazepine receptors which is demonstrated by the rever- 
sal of the behavioral and physiological responses by 
receptor antagonist administration. These observations 
in animals point to the early recognition of the anxi- 
olytic effects of benzodiazepines through the use of an 
impressive range of procedures. While generally vali- 
dated with benzodiazepines through the use of an 
impressive range of procedures. While generally vali- 
dated with benzodiazepine agonists and antagonists, 
the available experimental protocols differ considerably 
in terms of face validity, economy of training time and 
animal use. The implicit assumption for attenuating 
and reversing behavioral changes by benzodiazepine 
anxiolytics is that these behavioral effects are due to 
changes in affective or emotional processes. 
Partial and full 5HTIA agonists are characterized by 
systematic and potent effectiveness only in some of the 
"classic" punishment and fear-conditioning procedures 
(e.g., Przegalinski et al. 1992), but as will be discussed 
in detail below, more convincingly in those experi- 
mental procedures that engender so-called fear or dis- 
tress responses such as in rat pups separated from their 
mother and nest, in adult rats that are threatened by 
conspecifics, or that are in withdrawal "distress"; only 
few preclinical studies have given these drugs repeat- 
edly or chronically which is necessary for buspirone 
and ipsapirone to become effective in ameliorating 
GAD in humans (e.g., Pecknold t994). 
Most current experimental preparations have been 
effective predictors for treatment of GAD, but have 
been less successful for identifying drugs for the other 
types of anxiety. GAD, obsessive-compulsive disorders 
and panic disorders often benefit from different phar- 
macological treatments and appear to have different 
neurobiological mechanisms requiring separate pre- 
clinical behavioral procedures. 
Major experimental methods for studying the effects of 
anxiolyUcs on aggression 
The research strategies fbr delineating the role of 5-HT 
in aggressive behavior in animals and in clinical pop- 
ulations differ substantially from those for character- 
izing the benzodiazepines' effects on these behavior 
patterns. While many studies on 5-HT have relied upon 
correlating an index of serotonergic activity in brain 
tissue, blood or CSF with an "aggressive" trait, ben- 
zodiazepine research has developed a profile of drug 
effects on dominance, territorial and maternal aggres- 
sion as well as defensive reactions to attacks by rivals 
and predators. Illustrative evidence from these latter 
procedures is summarized in Table 2. 
Table 2 Experimental methods for studying the effects of anxiotyt- 
ics on aggression. CDP chtordiazepoxide, D Z P  diazepam, A L P  
alprazolam, BUS Busirone, GEP Gepirone, E L T  Eltoprazine, 
8-OH-DPAT 8-hydroxy-dipropylaminotetralin. All doses refer to 
intraperitoneal administration, unless stated: (PO) oral route; (SC) 
subcutaneous route. IM intramuscular route 
Method Benzodiazepine anxiolytics 










a) Male-female CDP 
housing 
b) Single-housed CDP 





Intruder rats DZP 
2.5-5 $ Miczek, (1974) 
20(IM) $ Miczek, (1974) 
5 $ Miczek and O'Donnell, 
20 $ (1980) 
5-20 $ Rodgers and Waters, 
(1985) 




0.3-1 $ Olivier et al. (1991) 
3-17 $ 
3 lO +/0 Vivian and Miczek 
(1993a) 
Tornatzky and Miczek 
(I995) 
BUS 2-8 $ 
8-OH-DPAT 0.1-0.2 $ 
(sc) 
ELT 1.25-5- $ 
BUS 1-10 0 
GEP 3-30 $ 
BUS 1-10 $ 
8-OH-DPAT 1-10 
BUS 0,3-3 0 
8-OH-DPAT 0,10.2 $ 
ELT 2-8 $ 
GEP 3---6 -J./O 
Mos et at. (1993) 
Gao (1993) 
Miczek, unpublished 
Olivier et al. 
(1989) 
Mos et al. (1992) 
Vivian and Miczek, 
(1993a) 




Benzodiazepine effects have been studied on all major 
types of aggressive behavior in animals (Table 2; e.g., 
Miczek and Krsiak 1979; Rodgers and Waters 1985; 
Miczek 1987; Mos et al. 1987; Sulcova and Krsiak 
1989; Krsiak and Sulcova 1990). Diazepam and other 
sedative-~pnotics such as alcohol share the feature of 
increasing aggressive behavior by resident rats con- 
fronting an intruder, when given at lower doses (Miczek 
1974; Miczek and Barry 1977; Olivier et al. 1984; 
Olivier et al. 1991; Miczek et al. 1992); however, at 
higher doses, these drugs decrease aggressive behavior, 
primarily due to their sedative and muscle-relaxant 
effects. The aggression-heightening effects of alcohol 
can be antagonized by benzodiazepine receptor antag- 
onists in resident rats and in dominant squirrel 
monkeys, but the aggression-decreasing effects remain 
unaltered by these antagonists (Weerts et al. 1993b). 
This is illustrated in alcohol-treated dominant squirrel 
monkeys that display aggressively and emit aggressive 
vocalizations toward lower ranking group members or 
rivals (Weerts and Miczek, unpublished). 
In singly or pair-housed mice that confront intrud- 
ers into their territory, chlordiazepoxide and midazo- 
lam increase aggressive behavior at low doses and 
decrease it at higher doses (Miczek and O'Donnell 
1980; Rodgers and Waters 1985). Similarly, in certain 
mice, particularly those with elevated levels of testos- 
terone, low alcohol doses increase aggressive behavior, 
whereas higher doses decrease it (DeBold and Miczek 
1985; Miczek et al., submitted). Antagonism and recep- 
tor binding studies point to the GABAa-benzodi- 
azepine receptor complex as the most likely site for the 
alcohol aggression-heightening effects (e.g., Weerts et 
al. 1992; Grant 1994; Miczek et al. 1994a). 
Similarly, the biphasic nature of the benzodiazepine 
effect on aggression is seen in maternal female rats and 
mice (Olivier et al. 1985; Yoshimura 1987). The increase 
in aggressive behavior is evident as more frequent pur- 
suits, threats and attacks after administration of low 
doses of benzodiazepines. Curiously, flumazenil failed 
to antagonize the increased aggressive behavior of lac- 
tating female rats after chlordiazepoxide treatment 
(Mos et al. t987). 
In contrast to the aggression-enhancing effects of 
benzodiazepines, these drugs dose-dependently attenu- 
ate flight responses in selectively bred timid mice 
(Krsiak 1975) and defensive responses in feral rats 
(Blanchard et al. 1989). In feral rats, intermediate doses 
of benzodiazepines specifically reduce defensive threat 
and attack without altering the remainder of the ago- 
nistic repertoire. The antagonist flumazenil attenuated 
the benzodiazepine inhibition of flight behavior in mice 
(Sulcova and Krsiak 1984). 
To summarize, benzodiazepines exert biphasic effects 
on aggressive behavior by a resident male confronting 
a territorial intruder, by rivals in dominance contests 
or by a lactating female defending her litter, i.e. lower 
doses increased aggressive behavior and higher doses 
decreased these behaviors. Defensive responses to 
conspecifics and predators are routinely decreased by 
benzodiazepines, although only at intermediate and 
higher doses that are sedative. 
Benzodiazepines' and alcohol's enhancement of 
aggressive behavior have been attributed to a disin- 
hibitory action similar to the release of inhibition of 
punished behavior. However, the similarity appears to 
be only superficial. First, in rats, the doses that are 
sufficient to increase aggressive behavior are almost ten- 
fold lower than those necessary to increase punished 
behavior. Also, increases in aggressive behavior after 
benzodiazepine treatment are not universal. For exam- 
ple, recently we observed large increases in low-rate 
operant behavior after alprazolam administration, but 
concurrent decreases in aggressive behavior in the same 
mice (Miczek, unpublished observations). In order to 
maintain a disinhibition hypothesis as a unifying prin- 
ciple for benzodiazepine effects on suppressed behav- 
ior and on aggressive behavior, it is necessary to 
postulate multiple inhibitory mechanisms, each depen- 
dent on the GABAa-benzodiazepine receptor complex. 
5-HT drugs 
No other neurotransmitter system has been more fre- 
quently linked to a broad range of aggressive behavior 
than serotonin. Several major families of serotonin 
receptors, each with several subtypes, are now recog- 
nized (Hoyer and Boddeke 1993; Hoyer et al. 1994). 
While the molecular cloning of these receptors pro- 
ceeds rapidly, understanding the functional significance 
of many of the newly identified receptor subtypes in 
different types of aggression and anxiety remains a chal- 
lenge at present (Wilkinson and Dourish 1991; Mos 
et al. 1992; Olivier et al. 1992; Barrett and Vanover 
1993). 
The preclinical stud?" of the role of 5-HT receptor 
subtypes in different types of aggressive behavior is at 
an early stage. This is surprising since the 5-HT 
deficiency hypothesis of violent and aggressive behav- 
ior has been reiterated during the past 2 decades with 
vigor and enthusiasm. Ever since Brodie and Shore 
(1957) proposed brain 5-HT to subserve an inhibitory 
role in behavior and autonomic nervous activity, Hess' 
tropotrophic system appeared to have a neurochemi- 
cal basis (Hess 1954). In fact, the tropotrophic role of 
serotonin continues to be the guiding principle for 
much preclinical and clinical aggression research. 
During the 1960s and 1970s, preclinical studies of 
fighting in singly housed mice and in mouse-killing rats 
associated low levels of brain 5-HT metabolites with a 
high incidence of fighting and killing (e.g., Garattini 
et al. 1967; Giacalone et al. 1968; Valzelli and Garattini 
1968; Valzelli and Bernasconi 1979; Valzelli 1982; 
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Pucilowski and Kostowski 1983; Valzelli and Galateo 
1984). Evidence from studies with highly aggressive 
humans with various antisocial, alcoholic or other 
diagnoses showed often an association with low 5- 
HIAA levels in spinal CSF (Brown et al. 1979; Linnoila 
et al. 1983; Virkkunen et al. 1989). 
These correlational studies between a single value of 
5-HT or its metabolite level in whole brain or cortical 
regions or CSF from spinal taps on the one hand, and 
a characteristic trait of excessive aggressive behavior 
on the other, remain inconclusive as to the causal rela- 
tionship between these neurochemical and behavioral 
variables. Single measures of blood platelet or CSF 
5-HIAA are ditficult to relate to regulatory events at 
pre- and postsynaptic sites of anatomically discrete 
5-HT neurons (Miczek et al. 1994b). 
The development of more selective agonists and 
antagonists at the 5-HT receptor subtypes that act at 
somatodendritic, presynaptic autoreceptors or postsy- 
naptic sites, associated with ion channel proteins or G 
proteins, is prompting research on their respective role 
in dominance, territorial and maternal aggressive 
behavior as well as defensive responses (Miczek et at. 
1989; Olivier et al. 1989; Mos et al. I992). Table 2 sum- 
marizes the key findings of drugs acting on 5-HT~ 
receptors on various aggressive behavior patterns in 
comparison with those of benzodiazepines. 
In confrontations with an intruder, resident male and 
female rats and mice engage in less frequent aggressive 
behavior after treatment with full agonists at 5-HT1A 
receptors, such as 8-OH-DPAT or flesinoxan, and par- 
tial agonists, such as buspirone, ipsapirone and 
gepirone (Oliver et al. 1990; Miczek and Haney, unpub- 
lished observations). 
By far the most  promising evidence on the role of 5- 
HT receptors in aggressive behavior has been collected 
with experimental manipulations that target the 5-HT1A. 
B receptors. Highly effective and behaviorally specific 
reductions in a range of aggressive behavior patterns 
have been achieved with piperazine derivatives that act 
as mixed agonists at 5-HT1B and 5-HT1A receptors. 
Olivier and associates have summarized the evidence 
that eltoprazine and the more 5-HTIB selective agonist 
TFMPP (m-trifluoromethylphenyl-piperazine) which 
also causes 5-HT release, decrease a resident rat's or 
mouse's attacks and threats toward an intruder, decrease 
a lactating female rat's attack toward an unfamiliar mate 
approaching the nest, increase the electrical current 
threshold for evoking attack leaps and bites by hypo- 
thalamic stimulation in rats toward a stimulus rat, and 
reduce the incidence of biting during the formation of 
dominance hierarchies among young pigs (Olivier et al. 
1990). The potent anti-aggressive effects across a range 
of animal species and situations is promising, although 
these "serenic" drugs may also increase responses to 
aversive events (Rodgers et al. 1992). 
When the 5-HT1B receptor is "knocked out" in 
mutant  male mice, their frequency of attack behavior 
is more than double that of heterozygous mice (Saudou 
et al. 1994). Interestingly, no unusual changes in repro- 
ductive or feeding behavior, pain responses or sleep- 
waking activity are seen in the 5-HT~B "knock-out" 
mice pointing to a relatively selective change in aggres- 
sive behavior. However, eltoprazine remains effective in 
decreasing aggressive behavior of these 5-HT~ B mutant  
mice suggesting that the 5-HT1A receptor continues to 
modulate this behavior (Hen et al. 1994). 
So far, the most specific modulations of aggressive 
behavior appear to be achieved via manipulations of 
the 5-HT~ receptor family, whereas 5-HT2 and 5-HT3 
antagonists suppress aggressive behavior with limited 
specificity. Remarkably, no 5-HT agonist or antagonist, 
acting pre-or post-synaptically, has been found to 
increase any type of aggressive behavior in animals. 
From a pharmacological viewpoint, the current 
characterization of the various 5-HT receptor subtypes 
in anxiety and aggression is tantalizing and frustrat- 
ing. For example, which are the requisite mechanistic 
changes during the period of chronic treatment with 
partial 5-HT~A agonists that are necessary for clinical 
effects to emerge? Pharmacologically, adequate "silent" 
antagonists only now are becoming available in order 
to establish the 5-HTIA receptor as the important  site 
of action for buspirone, ipsapirone or gepirone (e.g., 
Hoyer and Boddeke 1993; Hoyer et al. 1994; Fletcher 
et al. 1993) Similarly, the pharmacological tools for 
study of the 5-HTlwD and 5-HT3 receptors remain too 
limited in order to adequately characterize the role of 
these receptors in experimental protocols for the study 
of anxiety and aggressive behavior. 
Anxiolytics and affective vocalizations during aggression 
and anxiety 
A seemingly insurmountable challenge to prectinical 
research on anxiolytics is the experimental 
quantification of the affective or emotional dimension 
of anxiety and aggression. The premise for this quest 
may be traced to Darwin's argument that emotions have 
evolved in species other than humans. As a matter of 
fact, the neurobiological mechanisms tbr emotional 
behavior have been studied in a range of mammalian 
species, including non-human primates (MacLean 
1949; Skolnick and Paul 1982; Ploog 1989). Yet, 
preclinical psychopharmacological research on aggres- 
sion and anxiety in the behavior-analytic tradition has 
largely circumvented the direct study of emotional 
behavior, by inferring emotional processes from 
disrupted ongoing behavioral performance (e.g., Estes 
and Skinner 1941; Brady 1956). 
As summarized above, animal models are validated 
pharmacologically by their sensitivity to produce 
behavioral changes as a result of specific treatments 
rather than attempting to model specific changes in 
affect, i.e. pharmacological versus external validity. It 
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is important to recall that the critical defining features 
of many affective disorders, including anxiety, are their 
emotional nature and disruption of normal social func- 
tioning. Modeling specific affective expressions such as 
"fear" or "contentment" under socially relevant con- 
ditions may provide valuable insight in the neurobiol- 
ogy of anxiety that have not been adequately addressed 
in animal models (Mark and Ervin 1970; Redmond 
and Huang i979; Winslow and Insel 1991b). A com- 
mon characteristic of intense excitation when in pain 
or fear, is the emission of high-frequency calls. Both in 
mammals and in birds, the average frequency increases 
and the band of frequencies of individual vocalizations 
widens during fearful situations (Scherer 1986; Aubin 
and Bremond 1992). 
Vocalizations in mammals are the product of 
respiratory, laryngeal and articulatory movements that 
are the result of activity of cranial and spinal motor 
neurons in the brain stem that in turn receive modu- 
latory input from higher cerebral levels (Jfirgens 
and Ploog 1981). For example, anatomical studies in 
squirrel monkeys identify the anterior cingulate cortex, 
the basal amygdaloid nucleus, dorsomedial and lateral 
hypothalamus, and midline thalamus in addition to the 
caudal periaqueductal grey area as the most prominent 
structures that yield vocalizations when electrically 
stimulated. Also, in rats, electrical stimulation of 
thalamic, hypothalamic and mesencephalic as well as 
medullary structures evokes ultrasonic vocalizations in 
the 20-30 kHz range (Yajima et al. 1980, 1981). Among 
the neural structures that are most effective for 
evoking vocalizations are those where GABAA-benzo- 
diazepine receptor complexes and 5-HT receptors are 
localized (Young and Kuhar 1980; Zifa and Fillion 
1992). Whether modulation of vocalizations by anxi- 
olytic drugs reflects an alteration in affective processes 
or is a modification of activity in laryngeal or respira- 
tory activity remains a critical question. 
Before highlighting the significance of vocalizations 
in socially arousing situations, it may be useful to con- 
sider recent evidence on attempting to quantify the 
emotional component of behavior in response to painful 
and startling stimuli. 
Vocalizations in the context of pain and startle 
Preclinical methods in pain research include those that 
evoke vocalizations by rats; these sounds are typically 
in the hearing range of the human experimenter (e.g., 
Hammond 1989). The stimulus-evoked audible vocal- 
izations are sensitive to opioids' analgesic effects 
(Levine et al. 1984), and when withdrawn from chronic 
opiate treatment, rats "scream on touch" (Blfisig et al. 
1973). Additionally, rats emit audible vocalizations 
after the painful electrical stimulus has terminated; 
these so-called vocalization afterdischarges are sensi- 
tive to opiates and benzodiazepine anxiolytics, and they 
may detect affective aspects of pain (Levine et al. 1984; 
Borszcz et al. 1994). Yet, the rat's audible squeal actu- 
ally represents only a small fraction of its vocal 
responses immediately before, in reaction to a painful 
stimulus or after the termination of the stimulus. 
Additionally, single or bursts of ultrasonic vocaliza- 
tions, in anticipation or in reaction to painful stimuli, 
are emitted in the 20- to 30-kHz frequency range with 
little frequency modulation and are the prevailing vocal 
expressions (Tonoue et al. 1986; Van der Poel et al. 
1989; Van der Poel and Miczek 1991; De Vry et al. 
1993; Sanchez 1993; Molewijk et al. 1995). 
Opioid peptides, such as /~-endorphin, met- and 
leu-enkephalin, and dynorphin proved effective in 
reducing pain-induced ultrasonic vocalizations, but 
audible squeals in reaction to the electric shock 
pulse remained unaffected (Tonoue et al. 1986). The 
ultrasonic vocalizations in the "anticipatory" phase, 
before the delivery of electric pulses to the tail, were 
particularly sensitive to morphine's suppressive effects, 
which were reversed by naloxone (Van der Poel et al. 
1989). The environmental context that is associated 
with past electric shock deliveries is sufficient to induce 
ultrasonic vocalizations, and these calls may be inter- 
preted as affective expressions in anticipation of pain 
(Miczek et al. 1991b). Opioid modulation of ultrasonic 
vocalizations by rats that anticipate the delivery of a 
painful stimulus may in fact point to a significant role 
of opioid peptides as well as mu and delta receptors in 
affective responses. Further support for a significant 
role of opioid peptides in the modulation of affective 
responses may be adduced from the effects of specific 
opioid receptor subtype agonists on vocalizations of 
rats that have been startled by an acoustic or tactile 
stimulus. M u  and delta selective receptor agonists, 
such as DAGO and DPDPE, potently inhibit 20- 
to 32-kHz ultrasounds in a naltrexone-reversible man- 
ner in male intruder rats (Vivian and Miczek, in prepa- 
ration). These observations implicate mu and delta 
receptors in vocalization that may reflect affective 
distress. 
Consistent with this hypothesis is the observation 
that rats that are withdrawn from opiate treatment emit 
ultrasonic vocalizations (Vivian and Miczek 1991). In 
addition to the well-known "scream-on-touch" and 
other prominent signs of autonomic distress, morphine- 
withdrawn rats emit ultrasonic calls in the 20- to 30- 
kHz as well as the 40- to 60-kHz range for a longer 
period of time than the somatic and autonomic with- 
drawal symptoms. These ultrasounds are particularly 
prominent when the morphine-withdrawn rat is chal- 
lenged in a social situation or by a startling stimulus. 
Withdrawal from 30- or 60-day drinking of cocaine 
solution is also characterized by the emission of high 
rates of ultrasounds. This effect is most prominent dur- 
ing the first week after cocaine termination when the 
rats are challenged by tactile startle stimuli (Barros and 
Miczek 1994). 
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Evidence from recent studies with anxiolytic drugs 
provides important phaI~acological validation for the 
contention that ultrasonic vocalizations may represent 
affective expressions by rats that are exposed to star- 
tling or painful stimuli. Anxiolytics that target espe- 
cially 5-HTIA and benzodiazepine-GABAa receptors 
effectively decrease the rate and duration ofultrasounds 
in those rats that emit these 20- to 30-kHz calls, when 
exposed to acoustic startle stimuli (Kaltwasser 1991) 
or to foot shock, but not tail shock (Cuomo et al. 1988; 
Rowan et al. 1990; De Vry et al. 1993; Sanchez 1993; 
Cullen and Rowan 1994; but see Van der Poel et al. 
1989). No tolerance to the suppression of shock-elicited 
ultrasounds was seen with repeated administration of 
ipsapirone, and no rebound increase in calls was evi- 
dent when ipsapirone administrations were terminated 
(De Vry and Schreiber 1993). One day after the last of 
ten diazepam administrations rats emit increased ultra- 
sonic vocalizations, when prompted by acoustic startle 
stimuli (Miczek and Vivian 1993). Gepirone and 
diazepam reversed the increased ultrasound emission 
during diazepam withdrawal (Vivian et al. 1994a). It 
is, hovcever, noteworthy that buspirone has not been 
shown to be effective in the clinical management of 
benzodiazepine withdrawal (Schweizer and Rickels 
1986). When exposed to the environment where rats 
have received electric foot shock previously, they emit- 
ted fewer ultrasounds when given drugs with anti-panic 
activity such as alprazolam and 5-HT uptake blockers 
(Molewijk et al. 1995). 
Evidence from comparative, chronic, withdrawal and 
antagonism studies has begun to pharmacologically 
characterize the vocalizations by rats exposed to situa- 
tions where painful and startling stimuli are likely to 
occur. Potent and efficacious modulation of ultrasonic 
vocalizations and certain audible vocalization after dis- 
charges in rats appear to detect the selective effects of 
drugs acting on opiate, 5-HT~A and benzodiazepine 
receptors that may play a role in affective expressions. 
Vocalizations during social separation 
Separation from a major attachment figure is consid- 
ered as a primary cause of childhood separation anx- 
iety, anticipatory anxiety and over-anxiousness as well 
as for generalized anxiety and panic disorders in adults 
(DSM IV, American Psychiatric Association 1994). The 
etiology and pharmacological modulation of separa- 
tion distress in primates and other animals may be anal- 
ogous to that observed in humans (Panksepp et al. 
1978; Reite et al. 1981). 
Primates 
Vocalizations during social separation (i.e. "isolation 
calls") have been characterized pharmacologically 
more than other calls (Harris and Newman 1988; 
Newman 1988a; Kalin and Shetton 1989). Infant and 
juvenile primates separated from their mother or social 
group immediately respond with increased vocaliza- 
tions, agitation, and motor activity (Reite et al. 198t; 
Wiener et al. 1988; Suomi 1991), as well as increases 
in heart rate, body temperature, and circulating corti- 
sol levels and contact with the mother attenuates these 
changes (Mendoza et al. 1978; Coe et al. 1985). As 
social separation is prolonged, "protest" behaviors 
diminish and infants display "despair" (Suomi 1991). 
During the despair phase, infants typically display 
fewer vocalizations, a slouched posture, more self 
directed behaviors, less motor activity and fewer social 
interactions. 
In infant rhesus monkeys, separation-induced "dis- 
tress" vocalizations, defensive behaviors (e.g., freezing 
and crouching) and elevations in plasma ACTH and 
cortisol levels were reduced by diazepam (Kalin et al. 
1987). Flumazenil blocked the decreases in plasma 
ACTH and cortisol produced by diazepam, but not the 
reductions in vocalizations. Specifically, defensive 
"bark" calls were significantly decreased by diazepam, 
and unaffected by morphine or naloxone, whereas the 
affiliative "coo" calls were reduced by morphine and 
increased by naloxone but are unaltered by diazepam 
(Kalin et al. 1988; Kalin and Shelton 1989). 
SociMly separated infant and adult squirrel monkeys 
generally emit isolation "peeps" and show increased 
adrenal corticosteroid levels (Winter 1968; Symmes 
et al. 1979). In young animals these calls may solicit 
social contact with mother and group members 
(Newman 1988b), and tactile contact with the mother 
significantly reduces adrenal and vocal "distress" 
responses (Mendoza et al. 1978; Wiener et al. 1988; 
Weerts and Miczek, submitted). Recently, behavioral 
"protest" in reaction to social separation in juvenile 
squirrel monkeys was confirmed by characteristically 
high rates of "peep" vocalizations and explosive motor 
activity (Fig. 1; Weerts and Miczek, submitted). These 
vocalizations were hypothesized to be affective expres- 
sions of anxiety-like states produced by separation from 
the mother and familiar group members. Both vocal- 
izations and explosive motor behaviors were highly sen- 
sitive to full and partial benzodiazepine receptor 
agonists and to antagonists. The full agonist, chlor- 
diazepoxide, as well as the antagonist, flumazenil, dose- 
dependently reduced calls and explosive motor 
behaviors (e.g. rapid locomotion, jumping, leaping at 
and shaking the cage; Fig. 1). In contrast, the partial 
agonist bretazenil, which may be less sedative at anxi- 
olytic doses (Haefely et al. 1990), reduced calls only at 
very high doses. In addition, alcohol did not attenuate 
vocalizations, except at an ataxic dose. The potent 
anxiolytic-like effects of flumazenil on squirrel monkey 
"peeps" were closely similar to effects reported for iso- 
lated rat pup vocalizations (Insel et al. 1986; vide infra), 
although this effect is not always as significant as in 
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affective state of the animal, as suggested for separated 
rat pups (Inset et al. 1989). Although attractive, the evi- 
dence for an endogenous ligand remains to be sub- 
stantiated. Flumazenil's effects in preclinical procedures 
have been interpreted as both "anxiolytic" (e.g., 
increased social interactions, exploratory behaviors and 
feeding) and "anxiogenic" (e.g., reduced social behav- 
iors, partial generalization to PTZ) depending on the 
dose and testing situation (File and Pellow 1986; 
Haefely 1988; Weerts et al. 1993a). Also, squirrel mon- 
keys may be unusually sensitive to the partial agonist 
actions of flumazenil. Previously, squirrel monkeys 
were found to be more sensitive to benzodiazepine 
receptor antagonists such as flumazenil and ZK 93426 
and partial inverse agonist such as Ro 15-4513 than 
rodents. Flumazenil's hyperphagic effects as well as the 
proconvulsant effects of Ro 15-4513 were readily 
detected in squirrel monkeys, but not in rats (Weerts 
et al. 1993a). 
In selected adult squirrel monkeys, isolation "peep" 
calls were sensitive to opiate modulation; morphine sup- 
pressed isolation calls, whereas naloxone increased iso- 
lation calls and blocked the reductions in calls produced 
by morphine (Newman t988a). In addition, "peeps" 
were also suppressed by imipramine and clonidine, 
when tested 1 h after administration (Harris and 
Newman 1988). Clonidine-induced suppression of iso- 
lation "peeps" were reversed by yohimbine, but not by 
prazosin. However, yohimbine increased isolation 
"peeps" when administered alone (Harris and Newman 
1987). In addition to benzodiazepine anxiolytics, opi- 
oid and adrenergic systems also appear to modulate iso- 






Fig. IA Sonogram of "peep" vocalizations emitted by a juvenile 
squirrel monkey when separated from the native social group. B 
Effects of chlordiazepoxide on "peep" vocalizations by juvenile 
squirrel monkeys, and of diazepam on ultrasonic vocalization by 
rat pups. The data are expressed as a function of dose. C Sonogram 
of ultrasonic vocalizations emitted by a rat pup when separated 
from the littermates and dam. (Data from Weerts and Miczek, sub- 
mitted, and from Vivian et aL, submitted) 
juvenile rhesus monkeys' "distress" vocalizations 
(Kalin et al. 1987). 
Flumazenil may interact with endogenous sub- 
stances and exert different effects depending on the 
Young rodents 
When separated from the litter and mother and when 
exposed to cold or rough handling, neonatal rats and 
mice emit ultrasonic vocalizations as pure tone whis- 
tles, ranging in frequency from 20- to 60-kHz, and 0.1- 
to 3.5-s in duration (Fig. 1C). Benzodiazepine anxi- 
olytics, such as chlordiazepoxide and diazepam, 
decreased pup uttrasounds without altering locomotor 
behavior (Gardner 1985), while inverse agonists, such 
as DMCM, FG 7142 and pentylenetetrazol, increased 
ultrasounds (Insel et al. 1986; Gardner and Budhram 
1987; Nastiti et al. 1991). Flumazenil reversed the effects 
of agonists and inverse agonists implicating the benzo- 
diazepine receptor in the mediation of pup ultrasounds. 
Furthermore, socially isolated pups show decreased 
flumazenil binding in limbic structures (Insel 1989). 
GABA agonists such as muscimol and baclofen were 
found to decrease ultrasounds in mouse pups (Nastiti 
et al. 1991), and recently the role of the benzodiazepine- 
GABAA receptor complex in rat pup ultrasonic vocal- 
ization was more fully characterized (Fig. 1; Vivian 
et al., submitted). Allopregnanolone, a neurosteroid 
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Table 3 Vocalizations during aggression and anxiety -prototypic 
effects of anxiolytics. A V Audible vocalizations, USV Ultrasonic 
vocalizations, High USV 31~0 kHz, Low USV 20-30 kHz, CDP 
chlordiazepoxide, DZP diazepam, FNP flunitrazepam, BUS 
Buspirone, GEP Gepirone; IPS ipsapirone, 8-OH-DPAT 8-OH- 
dipropylaminotetralin. All doses refer to intraperitoneal adminis- 
tration, unless stated: (IM) intramuscular route 
Method Benzodiazepine anxiolytics 




Drug Dose Effect Reference 
(mg/kg) 
Aversive environmental stimuli (adult rats') 
Footshock DZP 0.5 1 $ 
Low USV 
Startle FNP 0.5 $ 
Low USV DZP 1 3 $ 
Social separation 
AV Primates DZP 1 $ 
COP 3-10 (IM) $ 
USV Rat pups DZP 2.5-10 
Aggression 
AV Primates CDP 0.3(IM) 1" 
Response to threat of  aggression (adult rats') 
a) "anticipatory" 
High USV DZP 6-10 $ 
Low USV DZP 1 10 0 
b) "reactive" 
High USV DZP 10 0 
Low USV DZP 1 10 0 
Cuomo (1988) BUS 0.3-10 $ 
GEP 1 5 $ 
8-OH-DPAT 0.06-0.24 
Kaltwasser (1991) IPS 5 ,[, 
Vivian et al. (1994a) GEP 0.6-1 $ 
Kalin et al. (1987) 
Weerts and Miczek, submitted 
Mos and Olivier (1989) BUS 1-3 $ 
8-OH-DPAT 0.1~.2 $ 
Weerts and Miczek, submitted 
Tornatzky and Miczek GEP 
(1995) 
GEP 
Tornatzky and Miczek GEP 
0995) 
Vivian and Miczek GEP 
(1993a) 
De Vry et aI. (1993) 
Cullen and Rowan (1994) 
Sanchez (1993) 
Kaltwasser (1991) 
Vivian et al. (1994a) 
Mos and Olivier (1989) 
0.3-6 0 Tornatzky and Miczek 
(1995) 
3 6  $ 
0.3-6 ,[, Tornatzky and Miczek 
(1995) 
3 6 .1, Vivian and Miczek (1993a) 
acting on this receptor complex, proved active in sup- 
pressing pup ultrasounds (Zimmerberg et al. 1994). 
Using the suppression of pup ultrasounds as a func- 
tional endpoint, the order of relative potency of agents 
acting on this receptor complex was muscimol > alpra- 
zolam > diazepam > pentobarbital = allopregnanolone 
> ethanol (Vivian, Ban-os and Miczek, submitted). The 
effects of diazepam and alprazolam were reversibly 
antagonized by flumazenil, and those of muscimol by 
biccuculine confirming the benzodiazepine and 
GABAA receptors as relevant for the suppression of 
pup ultrasounds. Allopregnanolone potentiated the 
suppressive effects of diazepam and atprazolam 
markedly, and those of pentobarbital moderately. 
Conversely, none of the antagonists of this receptor 
complex (i.e. flumazenil, bicuculline, and picrotoxin) 
altered the effects of allopregnanolone on pup ultra- 
sounds. 
The benzodiazepine-GABAA receptor complex con- 
tains receptor and recognition sites for chemically 
diverse agents, extending most recently to neuros- 
teroids, that are significant targets for modulating pup 
ultrasounds. It will be essential to decipher the neces- 
sary molecular configuration of novel substances with 
anxiolytic-like effects on these distress signals. 
The 5-HT~A agonists 8-OH-DPAT, flesinoxan, and 
the partial agonists gepirone, ipsapirone and buspirone, 
the 5-HT2 agonist DOI as well as the 5-HT uptake 
blockers such as fluvoxamine, zimelidine, and 
clomipramine proved effective in suppressing pup ultra- 
sounds (Hard and Engel 1988; Mos and Olivier 1989; 
Winslow and Insel 1990a, b). Interestingly, agonists at 
the 5-HT/u receptor TFMPP and CGS12066B increase 
the rate of pup ultrasounds. The present evidence points 
to 5-HTIA receptors as being significant targets for 
modulating pup ultrasounds. However, in order to 
implicate the 5-HTIa receptors in a selective suppres- 
sion of pup ultrasounds it will be important to reverse 
agonist effects. 
Separation-induced vocalizations were initially 
linked to opioid peptides and their receptors (Panksepp 
et al. 1978). Rat pup ultrasounds are suppressed by 
morphine and by selective mu and delta receptor ago- 
nists such as DAGO and DPDPE, while the kappa 
receptor selective agonist U50488H increased these 
vocalizations (Carden et al. 1990, 1994; Kehoe and 
Shoemaker 1991; Barr et al. 1994; but see Winslow and 
Inse11991a). The opposite effects ofmu and delta recep- 
tor agonists versus kappa receptor agonist parallels the 
putative reinforcing and aversive effects of these drugs 
and are consistent with their proposed role in affective 
behavior. 
Vocalizations during threatening situations 
Rodents and primates emit a range of loud and 
frequent vocalizations in response to the threats and 
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attacks of an aggressive opponent and as anti-preda- 
tor signals. Functionally, these calls may represent 
affective expressions, but they also may provide infor- 
mation about the sender, are part of defensive and sub- 
missive displays, and may warn conspecifics about 
imminent danger. Recent evidence indicates that these 
calls can be modified by mood-altering drugs, partic- 
ularly benzodiazepine and 5-HT drugs with anxiolytic 
and potentially antidepressant effects. 
Vocal responses to threats and attacks 
As many currently available anxiolytics are chiefly 
effective in anticipatory or generalized anxiety disor- 
ders (Molander 1982), it is not surprising that the most 
successful preclinical tests involve animals who antici- 
pate fear-provoking events as a result of conditioning 
(e.g., Estes and Skinner 1941). When a rat enters a 
locale that signals the presence of a potential attack- 
ing opponent, it begins to emit bursts of ultrasonic 
vocalizations in the 20-30 as well as 40-60 kHz range 
(Tornatzky and Miczek 1994, 1995). 
Diazepam and alcohol effectively attenuated high- 
frequency ultrasounds by intruder rats when they were 
exposed to the environment where they were previously 
attacked, while gepirone suppressed low-frequency 
ultrasounds (Tornatzky and Miczek 1995). In this early, 
anticipatory phase of a social confrontation, the emis- 
sion of ultrasounds is accompanied by tachycardia and 
hyperthermia, all of which were reduced by alcohol, 
diazepam and gepirone. These observations point to 
the phase preceding a social confrontation as engen- 
dering a constellation of behavioral acts, including 
vocal responses, and physiological changes that are 
particularly sensitive to the effects of drugs with an 
anxiolytic-like profile, albeit each with a different mech- 
anism of action. 
In fact, the marked behavioral and physiological 
activation in reaction to attacks by an aggressive 
opponent remains unaffected by anxiolytics in both 
experienced and inexperienced intruder rats (Vivian 
and Miczek 1993a; Tornatzky and Miczek 1995). 
During the reactive phase of a social confrontation, 
intruder rats' cardiovascular and thermoregulatory 
functions are maximally activated and upright and 
supine postures are accompanied by bursts of loud 
and frequent ultrasonic vocalizations. Even at sedative 
and muscle-relaxant doses, neither diazepam, alcohol 
nor gepirone affected the emission of audible and 
low-frequency ultrasonic vocalizations. It appears that 
drugs that are clinically effective in ameliorating 
generalized anxiety are ineffective in modulating 
vocalizations under conditions of high-intensity 
confrontations. It is noteworthy that morphine and 
the mu and delta receptor-selective agonists, DAGO 
and DPDPE decreased ultrasounds by male or 
female intruders while they were being attacked 
(Vivian and Miczek 1993b; Haney and Miczek 1994, 
submitted). 
When shielded from physical harm, intruder rats 
continue to emit low- and high-frequency ultrasonic 
vocalizations in response to the threats of an aggres- 
sive opponent. The intensity of a confrontation that 
relies upon postural displays and vocal responses is 
considerably lower than that during the actual fight as 
indicated by the magnitude of endocrine, cardiovascu- 
lar and thermoregulatory responses (Miczek et al. 
1991a). Under these threatening conditions gepirone 
decreased low-frequency ultrasounds in experienced 
and inexperienced intruder rats (Vivian and Miczek 
1993a; Tornatzky and Miczek 1995). Diazepam atten- 
uated the emission of high-frequency ultrasounds in 
animals that were threatened for the first time. 
Interestingly, drugs such as opiates and clonidine that 
have anxiolytic activity in some individuals, also were 
effective in reducing high-frequency ultrasounds in this 
phase of the social confrontation (Vivian and Miczek 
1993b; Haney and Miczek 1994; Tornatzky and Miczek 
1994). However, the suppression of high-frequency 
ultrasounds may be part of the sedative effects of 
diazepam, morphine and clonidine, since these effects 
are seen only at higher doses. 
A most intriguing pharmacological profile of effects 
on ultrasonic vocalizations during social confronta- 
tions is emerging. Drugs with known or putative anx- 
iolytic activity attenuate ultrasonic vocalizations in 
animals that anticipate a confrontation with an aggres- 
sive opponent, but not in those who actually defend 
and submit in an intense fight. This distinction between 
anticipatory and reactive phases of an encounter offers 
the opportunity to differentiate between drug effects 
that may be relevant to the generalized anxiety disor- 
der vs those that may correspond to panic states. 
Anti-predatory vocalizations 
Under field conditions, squirrel monkeys and vervet 
monkeys confronting aerial and carnivorous predators 
emit vocalizations with distinct structural elements 
and in specific frequency ranges (Struhsaker 1967; 
Seyfarth et at. 1980; Newman et al. 1983; Marler 1982). 
Benactyzine, an anticholinergic drug, prompted adult 
squirrel monkeys to emit higher rates of alarm calls 
in response to threatening objects presented by the 
experimenter, but not to increase isolation calls 
(Glowa and Newman 1986; Glowa et al. 1988). This 
effect was blocked by the cholinesterase inhibitor, 
physostigmine, indicating pharmacological specificity 
to cholinergic mechanisms. By contrast, yohimbine 
and naloxone increased squirrel monkey isolation 
calls out did not alter alarm calls (Harris and Newman 
1988). Vocalizations elicited during situations of 
isolation and alarm can be pharmacologically dis- 
sociated. 
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Whether or not antipredator alarm calls are 
modified by anxiolytic or antidepressant drugs, and 
whether these effects are selective, has begun to be 
addressed in confrontations between a cat and rats. 
When presented with a potential predator, a cat, male 
and particularly female rats emit ultrasonic vocaliza- 
tions, when in the presence of other colony members 
(Blanchard et al. 1990, 1991, 1992). Morphine, at an 
analgesic dose, suppressed these antipredator vocal- 
izations, but even sedative doses of alcohol and 
diazepam left these calls unchanged (Blanchard et al. 
1990; Shepherd et al. 1992; Blanchard, unpublished 
observations). It appears that the antipredator vocal- 
izations are important in the survival of the species, 
assuming a functional significance beyond expressions 
of "affect" or "distress", as these calls remain intact 
even in profoundly sedated individuals. 
Vocalizations during aggressive confrontations 
Vocalizations may represent signals that are critically 
significant to sender as well as receiver, in addition to 
being affective expressions. Successful communication 
of information during situations of conflict increases 
the survival of individuals as well as increasing the evo- 
lutionary fitness of the species (Smith 1985). For exam- 
ple, when confronting a rival, and prior to physical 
attack, dominant squirrel monkeys emit vocalizations 
such as cackle and harsh display calls (Jfirgens 1979). 
It is possible to evoke these types of calls (and others) 
by activating glutamate receptors or by blocking 
GABAA receptors in the periaqueductal grey region of 
squirrel monkeys, even in the absence of social provo- 
cation (Jiirgens and Lu 1993; Lu and Jfirgens 1993). 
Drugs acting on the benzodiazepine-GABAa recep- 
tor complex may interfere with the production and 
perception of social signals that communicate subor- 
dination or appeasement during social confrontations 
(e.g., Miczek et al. 1994). Initiation of aggressive behav- 
iors can be enhanced in alcohol-treated dominant male 
monkeys, whereas subordinates treated with alcohol are 
more often the rec!pient of aggressive interactions, pre- 
sumably due to inappropriate social signalling (Miczek 
et al. 1984; Winslow and Miczek 1985). 
When adult male squirrel monkeys confront an unfa- 
miliar male rival under experimental conditions, they 
display various visual and vocal threats (Weerts and 
Miczek, submitted), closely similar to those observed 
in the field (Newman 1985) as well as to those elicited 
by electrical brain stimulation of limbic structures 
(Jfirgens 1988). Vocalizations that accompany aggres- 
sive displays are "noisier", and calls with wider band 
frequency ranges have been interpreted to reflect greater 
levels of arousal and aversion (Jfirgens 1982), as well 
as "distress" and "maximum intensity" aggressive dis- 
plays (Newman 1985). Dominant squirrel monkeys' 
threat vocalizations, especially peeps, peaked during the 
first minute of aggressive encounters and declined dur- 
ing the course of the confrontation (Weerts and Miczek, 
submitted), as this habituation is characteristic for 
aggressive interactions in other species (e.g., Winslow 
and Miczek 1984; Miczek et at. 1992). However, nei- 
ther chlordiazepoxide nor alcohol "disinhibited" vocal 
behavior that was suppressed in habituated opponents. 
Chtordiazepoxide and alcohol substantially increased 
threat peeps during the first minute of aggressive inter- 
actions when they were most frequent. Aggressive dis- 
plays and threat peeps were maintained across a wide 
range of chlordiazepoxide doses, even though the high- 
est dose increased inactivity and produced ataxia. 
By contrast, vocalizations during feeding and affilia- 
tive behavior include peeps, twitter, chuck and cackle 
calls directed at familiar group members (Weerts, 
Macey and Miczek, submitted). Under these condi- 
tions, peep vocalizations were not altered by benzodi- 
azepines including chlordiazepoxide. It is evident that 
similarly structured calls are differentially altered by 
anxiolytic drugs depending on the social contexts. 
These observations suggest that situational influences 
such as provocation and interaction with other indi- 
viduals within the social context are critical determi- 
nants of benzodiazepine and alcohol effects on 
vocalizations and social behavior. 
The production and structure of vocalizations as well 
as subsequent behavioral responses are indeed context 
specific. In pigtailed macaques and rhesus monkeys, 
victims of aggression elicit structurally distinct vocal- 
izations when attacked by a dominant vs. a subordi- 
nate (Gouzoules et al. 1984), "recruiting" aide in a 
rank-dependent manner from other group members or 
kin. Playback studies indicate that vocalizations in the 
absence of the appropriate contextual cues fail to elicit 
predictable behavioral responses (Gouzoules et al. 
1984; Biben and Symmes 1991). 
Conclusions 
Preclinical research on drugs that modulate normal and 
pathological affective processes can derive considerable 
benefits from the study of vocalizations in animals. The 
validity of vocalizations as a focus for the study of anx- 
iolytic and other mood-altering drugs derives primar- 
ily from their occurrence in intense phases of 
reproduction, maternal separation, social conflict and 
confrontations with predators and distressing events. 
It has become apparent under which experimental con- 
ditions it is possible to engender different types of loud 
and frequent vocalizations in laboratory rodents and 
primates that correspond to those under field condi- 
tions. The methodological requirements for their accu- 
rate recording and quantitative analysis have become 
adequately established. In well-defined contexts, typi- 
cally including an audience, certain vocalizations may 
represent affective expressions which renders them 
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particularly attractive for research with anxiolytic and 
other mood-altering drugs. Pharmacological validity 
has become apparent when, for example, benzodi- 
azepines selectively attenuate a rat's ultrasonic vocal- 
ization in an antagonist-reversible manner. Drugs 
acting on 5-HT receptors, particularly on the 1A and 
1B/D subtypes effectively suppress vocalizations by 
maternally separated pups or by adults rats that 
anticipate a social confrontation or aversive environ- 
mental event. It appears quite feasible that experi- 
mental conditions can be developed prompting vocal 
expressions that are sensitive to drugs effective in the 
treatment of affective disturbances ranging from 
panic to depression. In addition to communicating 
affective expressions, vocalizations may also represent 
important messages that inform the receiver about crit- 
ical features of the sender. Many psychotropic 
drugs such as alcohol distort this communication and 
thereby disrupt the patterns of social and aggressive 
behavior. 
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